Jason McCarthy
Stock Analyst at Maxim Group
(1.19)
# 1,638
Out of 4,479 analysts
129
Total ratings
29.52%
Success rate
-14.56%
Average return
Main Sectors:
79 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VIRI Virios Therapeutics | Initiates: Buy | $1 | $0.23 | +327.35% | 1 | Jun 20, 2024 | |
| CNTX Context Therapeutics | Maintains: Buy | $4 → $10 | $1.84 | +443.48% | 2 | May 9, 2024 | |
| NRBO NeuroBo Pharmaceuticals | Initiates: Buy | $10 | $4.68 | +113.68% | 1 | May 8, 2024 | |
| TLPH Talphera | Initiates: Buy | $3 | $0.92 | +226.09% | 1 | May 6, 2024 | |
| LIPO Lipella Pharmaceuticals | Initiates: Buy | $2 | $0.44 | +354.44% | 1 | Apr 9, 2024 | |
| RZLT Rezolute | Initiates: Buy | $8 | $4.21 | +90.02% | 1 | Apr 9, 2024 | |
| ATAI Atai Life Sciences | Upgrades: Buy | $6 | $1.30 | +361.54% | 1 | Apr 3, 2024 | |
| MBRX Moleculin Biotech | Maintains: Buy | $45 → $20 | $3.57 | +460.22% | 1 | Mar 26, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $30 | $6.96 | +331.03% | 1 | Mar 19, 2024 | |
| BLTE Belite Bio | Initiates: Buy | $60 | $45.50 | +31.87% | 1 | Dec 14, 2023 | |
| ATXI Avenue Therapeutics | Initiates: Buy | $56 | $3.41 | +1,549.56% | 1 | Dec 11, 2023 | |
| RNXT RenovoRx | Downgrades: Hold | n/a | $1.13 | - | 2 | Nov 15, 2023 | |
| BNGO Bionano Genomics | Downgrades: Hold | n/a | $0.57 | - | 1 | Nov 13, 2023 | |
| CHRS Coherus BioSciences | Downgrades: Hold | n/a | $1.39 | - | 1 | Nov 8, 2023 | |
| BNOX Bionomics | Maintains: Buy | $7 → $10 | $0.71 | +1,313.43% | 2 | Sep 28, 2023 | |
| BCLI Brainstorm Cell Therapeutics | Downgrades: Hold | n/a | $0.35 | - | 3 | Sep 28, 2023 | |
| CYTH Cyclo Therapeutics | Upgrades: Buy | $4 | $1.21 | +230.58% | 2 | Sep 27, 2023 | |
| NLSP NLS Pharmaceutics AG | Downgrades: Hold | n/a | $0.20 | - | 4 | Sep 14, 2023 | |
| GANX Gain Therapeutics | Initiates: Buy | $10 | $1.20 | +736.82% | 1 | Sep 12, 2023 | |
| GNLX Genelux | Initiates: Buy | $40 | $1.71 | +2,239.18% | 1 | Sep 12, 2023 | |
| VTGN VistaGen Therapeutics | Maintains: Buy | $30 | $3.33 | +800.90% | 3 | Sep 5, 2023 | |
| MESO Mesoblast | Downgrades: Hold | n/a | $6.45 | - | 3 | Aug 7, 2023 | |
| GLMD Galmed Pharmaceuticals | Upgrades: Buy | $4 | $0.29 | +1,302.03% | 4 | Jul 24, 2023 | |
| KTRA Kintara Therapeutics | Upgrades: Buy | $14 | $0.26 | +5,303.32% | 2 | Jul 14, 2023 | |
| IMMP Immutep | Maintains: Buy | $8 → $10 | $1.88 | +431.91% | 2 | May 18, 2023 | |
| TCON TRACON Pharmaceuticals | Maintains: Buy | $160 → $60 | $0.95 | +6,215.79% | 1 | May 11, 2023 | |
| PSTV Plus Therapeutics | Maintains: Buy | $30 → $12 | $1.55 | +674.19% | 2 | May 3, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Buy | $10 → $18 | $1.08 | +1,566.67% | 3 | May 3, 2023 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $325 → $400 | $473.78 | -15.57% | 3 | May 3, 2023 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $0.72 | - | 2 | Mar 29, 2023 | |
| PBLA Panbela Therapeutics | Upgrades: Buy | $900 | $0.35 | +255,509.20% | 3 | Mar 20, 2023 | |
| ZVRA Zevra Therapeutics | Initiates: Buy | $12 | $4.36 | +175.23% | 1 | Mar 17, 2023 | |
| APRE Aprea Therapeutics | Initiates: Buy | $16 | $3.80 | +321.05% | 1 | Mar 10, 2023 | |
| UNCY Unicycive Therapeutics | Maintains: Buy | $3 → $6 | $0.48 | +1,150.00% | 2 | Mar 9, 2023 | |
| SNPX Synaptogenix | Downgrades: Hold | n/a | $4.02 | - | 2 | Dec 19, 2022 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $21 → $8 | $4.59 | +74.29% | 1 | Nov 16, 2022 | |
| ABVC ABVC BioPharma | Downgrades: Hold | n/a | $0.75 | - | 1 | Nov 16, 2022 | |
| INO Inovio Pharmaceuticals | Downgrades: Hold | n/a | $8.43 | - | 4 | Nov 9, 2022 | |
| GILD Gilead Sciences | Maintains: Buy | $84 → $92 | $68.40 | +34.50% | 3 | Oct 31, 2022 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $3 | $0.99 | +203.03% | 1 | Oct 6, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $8 → $5 | $0.63 | +693.65% | 1 | Aug 23, 2022 | |
| ADIL Adial Pharmaceuticals | Downgrades: Hold | n/a | $1.04 | - | 1 | Aug 17, 2022 | |
| ARDS Aridis Pharmaceuticals | Downgrades: Hold | n/a | $0.06 | - | 1 | Aug 16, 2022 | |
| KZIA Kazia Therapeutics | Downgrades: Hold | n/a | $0.21 | - | 1 | Aug 2, 2022 | |
| FEMY Femasys | Initiates: Buy | $5 | $1.11 | +350.45% | 1 | Jun 17, 2022 | |
| TTNP Titan Pharmaceuticals | Downgrades: Hold | n/a | $5.43 | - | 4 | May 26, 2022 | |
| GOVX GeoVax Labs | Reiterates: Buy | $90 | $3.31 | +2,619.03% | 2 | May 23, 2022 | |
| INVO INVO Bioscience | Initiates: Buy | $140 | $0.77 | +18,176.76% | 1 | Jan 19, 2022 | |
| KPRX Kiora Pharmaceuticals | Initiates: Buy | $900 | $4.44 | +20,170.27% | 1 | Jan 19, 2022 | |
| ACXP Acurx Pharmaceuticals | Initiates: Buy | n/a | $2.16 | - | 1 | Nov 29, 2021 | |
| CYBN Cybin | Downgrades: Hold | n/a | $0.26 | - | 1 | Nov 19, 2021 | |
| PTIX Protagenic Therapeutics | Initiates: Buy | n/a | $0.77 | - | 1 | Oct 29, 2021 | |
| INDP Indaptus Therapeutics | Upgrades: Buy | n/a | $2.44 | - | 1 | Oct 19, 2021 | |
| OMER Omeros | Downgrades: Hold | n/a | $3.85 | - | 4 | Oct 4, 2021 | |
| ATNF 180 Life Sciences | Initiates: Buy | $4,180 | $1.65 | +253,233.33% | 1 | Sep 15, 2021 | |
| CMPS COMPASS Pathways | Initiates: Buy | n/a | $5.96 | - | 1 | Jun 28, 2021 | |
| ENVB Enveric Biosciences | Initiates: Buy | n/a | $0.55 | - | 1 | Jun 28, 2021 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | n/a | $6.96 | - | 1 | Jun 28, 2021 | |
| CLNN Clene | Initiates: Buy | n/a | $0.33 | - | 1 | May 20, 2021 | |
| CWBR CohBar | Initiates: Buy | n/a | $0.51 | - | 1 | Apr 23, 2021 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | n/a | $6.03 | - | 1 | Apr 19, 2021 | |
| CODX Co-Diagnostics | Downgrades: Hold | n/a | $1.23 | - | 2 | Mar 29, 2021 | |
| MNOV MediciNova | Initiates: Buy | n/a | $1.40 | - | 1 | Mar 10, 2021 | |
| SAVA Cassava Sciences | Maintains: Buy | n/a | $11.79 | - | 2 | Feb 16, 2021 | |
| ARTL Artelo Biosciences | Upgrades: Buy | n/a | $1.32 | - | 2 | Jan 7, 2021 | |
| GLPG Galapagos NV | Initiates: Buy | n/a | $25.34 | - | 1 | Nov 19, 2020 | |
| TFFP TFF Pharmaceuticals | Initiates: Buy | $300 | $1.78 | +16,753.93% | 1 | Jul 8, 2020 | |
| DMAC DiaMedica Therapeutics | Initiates: Buy | n/a | $2.80 | - | 1 | Jul 8, 2020 | |
| CLRB Cellectar Biosciences | Initiates: Buy | n/a | $2.38 | - | 1 | Jun 23, 2020 | |
| APTO Aptose Biosciences | Initiates: Buy | n/a | $0.74 | - | 1 | Feb 20, 2020 | |
| ATOS Atossa Therapeutics | Upgrades: Buy | n/a | $1.16 | - | 1 | Dec 18, 2019 | |
| MTNB Matinas BioPharma Holdings | Maintains: Buy | n/a | $0.16 | - | 3 | Nov 13, 2018 | |
| SCYX SCYNEXIS | Maintains: Buy | n/a | $1.95 | - | 1 | Oct 16, 2018 | |
| ADMA ADMA Biologics | Maintains: Buy | n/a | $11.40 | - | 2 | Jul 27, 2018 | |
| SLS SELLAS Life Sciences Group | Maintains: Buy | n/a | $1.12 | - | 2 | Jul 20, 2018 | |
| BYSI BeyondSpring | Maintains: Buy | n/a | $2.36 | - | 1 | Jun 22, 2018 | |
| VKTX Viking Therapeutics | Maintains: Buy | n/a | $51.54 | - | 1 | Jun 1, 2018 | |
| BLFS BioLife Solutions | Maintains: Buy | n/a | $20.23 | - | 2 | May 11, 2018 | |
| BLUE bluebird bio | Downgrades: Hold | n/a | $0.92 | - | 3 | Dec 13, 2017 |
Virios Therapeutics
Jun 20, 2024
Initiates: Buy
Price Target: $1
Current: $0.23
Upside: +327.35%
Context Therapeutics
May 9, 2024
Maintains: Buy
Price Target: $4 → $10
Current: $1.84
Upside: +443.48%
NeuroBo Pharmaceuticals
May 8, 2024
Initiates: Buy
Price Target: $10
Current: $4.68
Upside: +113.68%
Talphera
May 6, 2024
Initiates: Buy
Price Target: $3
Current: $0.92
Upside: +226.09%
Lipella Pharmaceuticals
Apr 9, 2024
Initiates: Buy
Price Target: $2
Current: $0.44
Upside: +354.44%
Rezolute
Apr 9, 2024
Initiates: Buy
Price Target: $8
Current: $4.21
Upside: +90.02%
Atai Life Sciences
Apr 3, 2024
Upgrades: Buy
Price Target: $6
Current: $1.30
Upside: +361.54%
Moleculin Biotech
Mar 26, 2024
Maintains: Buy
Price Target: $45 → $20
Current: $3.57
Upside: +460.22%
Actinium Pharmaceuticals
Mar 19, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $6.96
Upside: +331.03%
Belite Bio
Dec 14, 2023
Initiates: Buy
Price Target: $60
Current: $45.50
Upside: +31.87%
Avenue Therapeutics
Dec 11, 2023
Initiates: Buy
Price Target: $56
Current: $3.41
Upside: +1,549.56%
RenovoRx
Nov 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.13
Upside: -
Bionano Genomics
Nov 13, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.57
Upside: -
Coherus BioSciences
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.39
Upside: -
Bionomics
Sep 28, 2023
Maintains: Buy
Price Target: $7 → $10
Current: $0.71
Upside: +1,313.43%
Brainstorm Cell Therapeutics
Sep 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.35
Upside: -
Cyclo Therapeutics
Sep 27, 2023
Upgrades: Buy
Price Target: $4
Current: $1.21
Upside: +230.58%
NLS Pharmaceutics AG
Sep 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.20
Upside: -
Gain Therapeutics
Sep 12, 2023
Initiates: Buy
Price Target: $10
Current: $1.20
Upside: +736.82%
Genelux
Sep 12, 2023
Initiates: Buy
Price Target: $40
Current: $1.71
Upside: +2,239.18%
VistaGen Therapeutics
Sep 5, 2023
Maintains: Buy
Price Target: $30
Current: $3.33
Upside: +800.90%
Mesoblast
Aug 7, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.45
Upside: -
Galmed Pharmaceuticals
Jul 24, 2023
Upgrades: Buy
Price Target: $4
Current: $0.29
Upside: +1,302.03%
Kintara Therapeutics
Jul 14, 2023
Upgrades: Buy
Price Target: $14
Current: $0.26
Upside: +5,303.32%
Immutep
May 18, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $1.88
Upside: +431.91%
TRACON Pharmaceuticals
May 11, 2023
Maintains: Buy
Price Target: $160 → $60
Current: $0.95
Upside: +6,215.79%
Plus Therapeutics
May 3, 2023
Maintains: Buy
Price Target: $30 → $12
Current: $1.55
Upside: +674.19%
Reviva Pharmaceuticals Holdings
May 3, 2023
Maintains: Buy
Price Target: $10 → $18
Current: $1.08
Upside: +1,566.67%
Vertex Pharmaceuticals
May 3, 2023
Maintains: Buy
Price Target: $325 → $400
Current: $473.78
Upside: -15.57%
Monopar Therapeutics
Mar 29, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.72
Upside: -
Panbela Therapeutics
Mar 20, 2023
Upgrades: Buy
Price Target: $900
Current: $0.35
Upside: +255,509.20%
Zevra Therapeutics
Mar 17, 2023
Initiates: Buy
Price Target: $12
Current: $4.36
Upside: +175.23%
Aprea Therapeutics
Mar 10, 2023
Initiates: Buy
Price Target: $16
Current: $3.80
Upside: +321.05%
Unicycive Therapeutics
Mar 9, 2023
Maintains: Buy
Price Target: $3 → $6
Current: $0.48
Upside: +1,150.00%
Synaptogenix
Dec 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.02
Upside: -
Achieve Life Sciences
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $8
Current: $4.59
Upside: +74.29%
ABVC BioPharma
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.75
Upside: -
Inovio Pharmaceuticals
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $8.43
Upside: -
Gilead Sciences
Oct 31, 2022
Maintains: Buy
Price Target: $84 → $92
Current: $68.40
Upside: +34.50%
Oncolytics Biotech
Oct 6, 2022
Initiates: Buy
Price Target: $3
Current: $0.99
Upside: +203.03%
VolitionRx
Aug 23, 2022
Maintains: Buy
Price Target: $8 → $5
Current: $0.63
Upside: +693.65%
Adial Pharmaceuticals
Aug 17, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.04
Upside: -
Aridis Pharmaceuticals
Aug 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.06
Upside: -
Kazia Therapeutics
Aug 2, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.21
Upside: -
Femasys
Jun 17, 2022
Initiates: Buy
Price Target: $5
Current: $1.11
Upside: +350.45%
Titan Pharmaceuticals
May 26, 2022
Downgrades: Hold
Price Target: n/a
Current: $5.43
Upside: -
GeoVax Labs
May 23, 2022
Reiterates: Buy
Price Target: $90
Current: $3.31
Upside: +2,619.03%
INVO Bioscience
Jan 19, 2022
Initiates: Buy
Price Target: $140
Current: $0.77
Upside: +18,176.76%
Kiora Pharmaceuticals
Jan 19, 2022
Initiates: Buy
Price Target: $900
Current: $4.44
Upside: +20,170.27%
Acurx Pharmaceuticals
Nov 29, 2021
Initiates: Buy
Price Target: n/a
Current: $2.16
Upside: -
Cybin
Nov 19, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.26
Upside: -
Protagenic Therapeutics
Oct 29, 2021
Initiates: Buy
Price Target: n/a
Current: $0.77
Upside: -
Indaptus Therapeutics
Oct 19, 2021
Upgrades: Buy
Price Target: n/a
Current: $2.44
Upside: -
Omeros
Oct 4, 2021
Downgrades: Hold
Price Target: n/a
Current: $3.85
Upside: -
180 Life Sciences
Sep 15, 2021
Initiates: Buy
Price Target: $4,180
Current: $1.65
Upside: +253,233.33%
COMPASS Pathways
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $5.96
Upside: -
Enveric Biosciences
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $0.55
Upside: -
Mind Medicine (MindMed)
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $6.96
Upside: -
Clene
May 20, 2021
Initiates: Buy
Price Target: n/a
Current: $0.33
Upside: -
CohBar
Apr 23, 2021
Initiates: Buy
Price Target: n/a
Current: $0.51
Upside: -
Fennec Pharmaceuticals
Apr 19, 2021
Initiates: Buy
Price Target: n/a
Current: $6.03
Upside: -
Co-Diagnostics
Mar 29, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.23
Upside: -
MediciNova
Mar 10, 2021
Initiates: Buy
Price Target: n/a
Current: $1.40
Upside: -
Cassava Sciences
Feb 16, 2021
Maintains: Buy
Price Target: n/a
Current: $11.79
Upside: -
Artelo Biosciences
Jan 7, 2021
Upgrades: Buy
Price Target: n/a
Current: $1.32
Upside: -
Galapagos NV
Nov 19, 2020
Initiates: Buy
Price Target: n/a
Current: $25.34
Upside: -
TFF Pharmaceuticals
Jul 8, 2020
Initiates: Buy
Price Target: $300
Current: $1.78
Upside: +16,753.93%
DiaMedica Therapeutics
Jul 8, 2020
Initiates: Buy
Price Target: n/a
Current: $2.80
Upside: -
Cellectar Biosciences
Jun 23, 2020
Initiates: Buy
Price Target: n/a
Current: $2.38
Upside: -
Aptose Biosciences
Feb 20, 2020
Initiates: Buy
Price Target: n/a
Current: $0.74
Upside: -
Atossa Therapeutics
Dec 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $1.16
Upside: -
Matinas BioPharma Holdings
Nov 13, 2018
Maintains: Buy
Price Target: n/a
Current: $0.16
Upside: -
SCYNEXIS
Oct 16, 2018
Maintains: Buy
Price Target: n/a
Current: $1.95
Upside: -
ADMA Biologics
Jul 27, 2018
Maintains: Buy
Price Target: n/a
Current: $11.40
Upside: -
SELLAS Life Sciences Group
Jul 20, 2018
Maintains: Buy
Price Target: n/a
Current: $1.12
Upside: -
BeyondSpring
Jun 22, 2018
Maintains: Buy
Price Target: n/a
Current: $2.36
Upside: -
Viking Therapeutics
Jun 1, 2018
Maintains: Buy
Price Target: n/a
Current: $51.54
Upside: -
BioLife Solutions
May 11, 2018
Maintains: Buy
Price Target: n/a
Current: $20.23
Upside: -
bluebird bio
Dec 13, 2017
Downgrades: Hold
Price Target: n/a
Current: $0.92
Upside: -